Position in AHCO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$929,580
+$829,333 QoQ
Shares Held
78,116
+676.1% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AHCO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Campbell & CO Investment Adviser LLC holds $36,932,990 across 21 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
29,009 | $6,108,425 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
14,056 | $4,126,982 | |
| 3 | TXG |
10x Genomics, Inc.
|
102,568 | $3,932,457 | |
| 4 | ENOV |
Enovis CORP
|
139,970 | $2,897,379 | |
| 5 | HAE |
Haemonetics Corp
|
36,844 | $2,763,300 | |
| 6 | IRTC |
iRhythm Holdings, Inc.
|
22,024 | $2,619,754 | |
| 7 | ABT |
Abbott Laboratories
|
27,012 | $2,451,068 | |
| 8 | PODD |
Insulet Corp
|
12,102 | $1,842,529 |
All Filings in AHCO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $929,580 | 78,116 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $100,247 | 10,065 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $96,507 | 10,783 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $195,380 | 20,719 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,387,996 | 128,044 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,271,329 | 133,543 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,278,928 | 113,885 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $830,960 | 83,096 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $524,107 | 45,535 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $102,278 | 14,030 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $100,054 | 10,995 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||